13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q2 2024 · Filed August 13, 2024 · Accession 0000950123-24-008094
Total Value
$91.6M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,266,934 | $53.1M | 58.01% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 20,162,332 | $29.2M | 31.93% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $9.2M | 10.06% |